IMVT – immunovant, inc. (US:NASDAQ)
Stock Stats
News
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus [Yahoo! Finance]
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024
Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting
Form SC 13G/A Immunovant, Inc. Filed by: FMR LLC
Form 10-Q Immunovant, Inc. For: Sep 30
Form 8-K Immunovant, Inc. For: Nov 07
Form 4 Immunovant, Inc. For: Oct 23 Filed by: Levine Mark S.
Form 4 Immunovant, Inc. For: Oct 23 Filed by: Geffner Michael
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.